Evidence map›Paper›PMID 41682944›Full record

ReviewJournal of clinical medicine2026

Peripheral Ulcerative Keratitis: Pathogenesis, Diagnosis, and Multimodal Management.

Jose Carlos Guerrero-Acosta, Gustavo Ortiz-Morales, Guillermo Raul Vera-Duarte, Alejandro Navas, Enrique O Graue-Hernandez, Arturo Ramirez-Miranda

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jose Carlos Guerrero-AcostaInstituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City 06800, Mexico.ORCID 0009-0004-7624-4252
Gustavo Ortiz-MoralesInstituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City 06800, Mexico.ORCID 0000-0003-4217-8985
Guillermo Raul Vera-DuarteInstituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City 06800, Mexico.ORCID 0000-0002-3417-256X
Alejandro NavasInstituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City 06800, Mexico.ORCID 0000-0002-9417-5711
Enrique O Graue-HernandezInstituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City 06800, Mexico.ORCID 0000-0003-3267-3915
Arturo Ramirez-MirandaInstituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City 06800, Mexico.ORCID 0000-0001-6419-5116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral ulcerative keratitis (PUK) is a sight-threatening corneal disorder characterized by progressive peripheral stromal thinning and ulceration. It often reflects an underlying systemic autoimmune or vasculitic disease and may herald severe morbidity or even mortality. This review offers a comprehensive synthesis of current knowledge on the pathophysiology, clinical presentation, diagnostic approach, and management strategies for PUK, with a special focus on idiopathic forms such as Mooren's ulcer. We explore the immunological mechanisms driving peripheral corneal destruction, including the roles of complement activation, matrix metalloproteinases, and systemic immune dysregulation. A detailed classification of etiologies, including systemic autoimmune diseases, infectious causes, and iatrogenic forms, is presented, along with recommendations for diagnosis, laboratory workup, and differential diagnosis. Management strategies are reviewed in a stepladder approach, from local anti-collagenase and immunomodulatory therapy to systemic immunosuppressants and biologics, and, when necessary, surgical intervention.

Indexed as

corneal meltdry eye diseaseimmunosuppressive therapyperipheral ulcerative keratitisreviewsystemic vasculitis

Identifiers

PMID41682944
PMCPMC12898829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.